Kit L. Shaw

2.1k total citations
16 papers, 331 citations indexed

About

Kit L. Shaw is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Kit L. Shaw has authored 16 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Kit L. Shaw's work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Kit L. Shaw is often cited by papers focused on Virus-based gene therapy research (7 papers), CAR-T cell therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Kit L. Shaw collaborates with scholars based in United States, Canada and Switzerland. Kit L. Shaw's co-authors include Mark J. Mulligan, Paul A. Goepfert, Donald B. Kohn, Gerd Ritter, Anju Bansal, Bradley H. Edwards, Dirk Lindemann, George Wang, Heather Daley and Fabio Candotti and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Kit L. Shaw

16 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kit L. Shaw United States	11	145	131	94	87	82	16	331
Chin-Kai Chuang Taiwan	13	114 0.8×	282 2.2×	30 0.3×	61 0.7×	72 0.9×	33	492
Jörg Zielonka Germany	11	148 1.0×	105 0.8×	46 0.5×	233 2.7×	276 3.4×	11	427
Yadvinder S. Ahi United States	11	205 1.4×	205 1.6×	62 0.7×	121 1.4×	57 0.7×	12	461
Jes Kuruvilla United States	8	91 0.6×	281 2.1×	28 0.3×	42 0.5×	97 1.2×	9	513
Jesse Thompson United States	12	252 1.7×	275 2.1×	93 1.0×	104 1.2×	113 1.4×	19	525
Jonathan Hare United States	7	56 0.4×	143 1.1×	64 0.7×	62 0.7×	102 1.2×	30	321
Yajin Ni United States	7	152 1.0×	182 1.4×	60 0.6×	60 0.7×	82 1.0×	10	289
Jörn Stitz Germany	16	384 2.6×	393 3.0×	84 0.9×	100 1.1×	158 1.9×	42	650
Charlotte Dalba France	9	107 0.7×	102 0.8×	39 0.4×	209 2.4×	49 0.6×	10	391
Howard E. Davis United States	4	206 1.4×	240 1.8×	68 0.7×	66 0.8×	46 0.6×	8	417

Countries citing papers authored by Kit L. Shaw

Since Specialization

Citations

This map shows the geographic impact of Kit L. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit L. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit L. Shaw more than expected).

Fields of papers citing papers by Kit L. Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit L. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit L. Shaw. The network helps show where Kit L. Shaw may publish in the future.

Co-authorship network of co-authors of Kit L. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Kit L. Shaw. A scholar is included among the top collaborators of Kit L. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit L. Shaw. Kit L. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jurkunas, Ula V., Aaron R. Kaufman, Jia Yin, et al.. (2025). Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US. Nature Communications. 16(1). 1607–1607. 6 indexed citations

Jurkunas, Ula V., Jia Yin, Sanming Li, et al.. (2023). Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety. Science Advances. 9(33). eadg6470–eadg6470. 20 indexed citations

Frigault, Matthew J., Michael R. Bishop, Jacalyn Rosenblatt, et al.. (2022). Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood Advances. 7(5). 768–777. 50 indexed citations

Hanna, Glenn J., Robert Redd, A. Alonso, et al.. (2022). Abstract CT540: A phase 1 trial of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy with IL-15 superagonist in advanced head and neck cancer: Part 1 results. Cancer Research. 82(12_Supplement). CT540–CT540. 3 indexed citations

Frigault, Matthew J., Yi‐Bin Chen, Kathleen Gallagher, et al.. (2021). Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies. Blood. 138(Supplement 1). 653–653. 11 indexed citations

Liu, Siyu, Maja Krajinović, Marc Ansari, et al.. (2020). Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy. Biology of Blood and Marrow Transplantation. 26(10). 1819–1827. 5 indexed citations

Cooper, Aaron, Georgia R. Lill, Kit L. Shaw, et al.. (2017). Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood. 129(19). 2624–2635. 22 indexed citations

Shaw, Kit L. & Donald B. Kohn. (2011). A Tale of Two SCIDs. Science Translational Medicine. 3(97). 97ps36–97ps36. 14 indexed citations

Sokolic, Robert, Irina Marić, Chimene Kesserwan, et al.. (2011). Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood. 118(10). 2688–2694. 27 indexed citations

10.

Park, Jean, Tamás Alexy, Vahagn C. Nikolian, et al.. (2010). Regulated Expansion of Human Pancreatic β-Cells. Molecular Therapy. 18(7). 1389–1396. 1 indexed citations

11.

Shaw, Kit L., Shundi Ge, Cinnamon L Hardee, et al.. (2009). Lentiviral vectors with amplified β cell-specific gene expression. Gene Therapy. 16(8). 998–1008. 6 indexed citations

12.

Jang, Jung‐Eun, Kit L. Shaw, Xiaojin Yu, et al.. (2006). Specific and Stable Gene Transfer to Human Embryonic Stem Cells Using Pseudotyped Lentiviral Vectors. Stem Cells and Development. 15(1). 109–117. 24 indexed citations

13.

Shaw, Kit L., Dirk Lindemann, Mark J. Mulligan, & Paul A. Goepfert. (2003). Foamy Virus Envelope Glycoprotein Is Sufficient for Particle Budding and Release. Journal of Virology. 77(4). 2338–2348. 30 indexed citations

14.

Bansal, Anju, Kit L. Shaw, Bradley H. Edwards, Paul A. Goepfert, & Mark J. Mulligan. (2000). Characterization of the R572T Point Mutant of a Putative Cleavage Site in Human Foamy Virus Env. Journal of Virology. 74(6). 2949–2954. 17 indexed citations

15.

Goepfert, Paul A., Kit L. Shaw, George Wang, et al.. (1999). An Endoplasmic Reticulum Retrieval Signal Partitions Human Foamy Virus Maturation to Intracytoplasmic Membranes. Journal of Virology. 73(9). 7210–7217. 34 indexed citations

16.

Goepfert, Paul A., Kit L. Shaw, Gerd Ritter, & Mark J. Mulligan. (1997). A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. Journal of Virology. 71(1). 778–784. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact